Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis- CloPidogREl for Primary preVENTION (HOST-PREVENTION)
Condition:   Coronary Artery Disease Interventions:   Drug: Clopidogrel treatment group;   Other: No antiplatelet or anticoagulant group Sponsors:   Seoul National University Hospital;   Hallym University Kangnam Sacred Heart Hospital;   Hallym University Medical Center;   Hanyang University;   Keimyung University Dongsan Medical Center;   Kangbuk Samsung Hospital;   Wonju Severance Christian Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 6, 2023 Category: Research Source Type: clinical trials

Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis- CloPidogREl for Primary preVENTION (HOST-PREVENTION)
Condition:   Coronary Artery Disease Interventions:   Drug: Clopidogrel treatment group;   Other: No antiplatelet or anticoagulant group Sponsor:   Seoul National University Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 5, 2023 Category: Research Source Type: clinical trials

Antiplatelet Therapies in Patients With Depression and Coronary Disease
Conditions:   Coronary Artery Disease;   Depression Interventions:   Other: standard Aspirin (ASA) + clopidogrel (CLP) therapy;   Other: standard Aspirin (ASA) + Ticagrelor (TCG) or Prasugrel (PSG) therapy;   Other: standard ASA therapy Sponsors:   Centro Cardiologico Monzino;   IRCCS National Neurological Institute " C. Mondino " Foundation Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 20, 2023 Category: Research Source Type: clinical trials